Growth Metrics

Insulet (PODD) Liabilities and Shareholders Equity (2010 - 2026)

Insulet posted quarterly Liabilities and Shareholders Equity of $3.0 billion for Q1 2026, down 15.07% year-on-year from $3.5 billion in Q1 2025, and down 6.37% on a QoQ basis from $3.2 billion in Q4 2025.

Insulet (PODD) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $3.0 billion in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 15.07% year-over-year to $3.0 billion; the trailing twelve-month figure through Mar 2026 stood at $12.7 billion (up 1.31% YoY), and the FY2025 full-year result was $3.2 billion, up 3.33% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $3.0 billion, down from $3.2 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $3.5 billion in Q1 2025 and bottomed at $2.1 billion in Q1 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $2.6 billion (2024), against an average of $2.7 billion.
  • The widest annual swing landed in 2025, when Liabilities and Shareholders Equity soared 34.04%; it then declined 15.07% in 2026.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.3 billion in 2022, then grew by 14.97% to $2.6 billion in 2023, then increased by 19.3% to $3.1 billion in 2024, then climbed by 3.33% to $3.2 billion in 2025, then retreated by 6.37% to $3.0 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $3.0 billion (Q1 2026), $3.2 billion (Q4 2025), and $3.0 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 110.43 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 46.29 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 37.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 10.74 Bn
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 2.99 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.99 Bn
Dec 31, 2025 3.19 Bn
Sep 30, 2025 3.03 Bn
Jun 30, 2025 3.47 Bn
Mar 31, 2025 3.52 Bn
Dec 31, 2024 3.09 Bn
Sep 30, 2024 3.03 Bn
Jun 30, 2024 2.88 Bn
Mar 31, 2024 2.62 Bn
Dec 31, 2023 2.59 Bn
Sep 30, 2023 2.47 Bn
Jun 30, 2023 2.39 Bn
Mar 31, 2023 2.29 Bn
Dec 31, 2022 2.25 Bn
Sep 30, 2022 2.17 Bn
Jun 30, 2022 2.11 Bn
Mar 31, 2022 2.07 Bn
Dec 31, 2021 2.05 Bn
Sep 30, 2021 2.00 Bn
Jun 30, 2021 1.92 Bn
Mar 31, 2021 1.84 Bn
Dec 31, 2020 1.87 Bn
Sep 30, 2020 1.71 Bn
Jun 30, 2020 1.63 Bn
Mar 31, 2020 1.11 Bn
Dec 31, 2019 1.14 Bn
Sep 30, 2019 1.27 Bn
Jun 30, 2019 977.72 Mn
Mar 31, 2019 952.61 Mn
Dec 31, 2018 928.70 Mn
Sep 30, 2018 886.31 Mn
Jun 30, 2018 838.86 Mn
Mar 31, 2018 829.76 Mn
Dec 31, 2017 816.74 Mn
Sep 30, 2017 500.35 Mn
Jun 30, 2017 459.33 Mn
Mar 31, 2017 444.96 Mn
Dec 31, 2016 456.65 Mn
Sep 30, 2016 453.20 Mn
Jun 30, 2016 263.05 Mn
Mar 31, 2016 254.77 Mn
Dec 31, 2015 275.13 Mn
Sep 30, 2015 293.12 Mn
Jun 30, 2015 300.39 Mn
Mar 31, 2015 305.72 Mn
Dec 31, 2014 297.18 Mn
Sep 30, 2014 301.20 Mn
Jun 30, 2014 325.33 Mn
Mar 31, 2014 288.53 Mn
Dec 31, 2013 287.96 Mn
Sep 30, 2013 289.50 Mn
Jun 30, 2013 286.15 Mn
Mar 31, 2013 280.90 Mn
Dec 31, 2012 198.06 Mn
Sep 30, 2012 203.38 Mn
Jun 30, 2012 203.68 Mn
Mar 31, 2012 215.68 Mn
Dec 31, 2011 221.32 Mn
Sep 30, 2011 228.34 Mn
Jun 30, 2011 238.75 Mn
Dec 31, 2010 156.23 Mn